Fierce Pharma:Tiny biotech Errant sues Bluebird for patent infringement in developing gene therapy LentiGlobin

Oct 25, 2021 | News

The ongoing battle between gene therapy biotechs Bluebird Bio and Errant has finally reached the patent infringement stage.

Last week, in U.S. District Court in Delaware, Errant Gene Therapeutics, a tiny Chicago company, filed a lawsuit alleging that Bluebird of Massachusetts infringed its patents for a recombinant vector used in the manufacture of the treatment of two rare blood disorders.

View the rest of the article here

View the PDF

Contact us

Call Us

+1 (312) 441-1800

Our Locations

San Rocco Therapeutics
308 E. Emily St.
Tampa, FL 33603


Get in touch